Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, Plants J, Seth A, Wilson CC, Deeks SG, Lederman MM, Landay AL. Tenorio AR, et al. Among authors: lederman mm. J Infect Dis. 2014 Oct 15;210(8):1248-59. doi: 10.1093/infdis/jiu254. Epub 2014 May 1. J Infect Dis. 2014. PMID: 24795473 Free PMC article.
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team.
Haubrich RH, Flexner C, Lederman MM, Hirsch M, Pettinelli CP, Ginsberg R, Lietman P, Hamzeh FM, Spector SA, Richman DD. Haubrich RH, et al. Among authors: lederman mm. J Infect Dis. 1995 Nov;172(5):1246-52. doi: 10.1093/infdis/172.5.1246. J Infect Dis. 1995. PMID: 7594660 Clinical Trial.
Human immunodeficiency virus type 1 activation after blood transfusion.
Mudido PM, Georges D, Dorazio D, Yen-Lieberman B, Bae S, O'Brien WA, Spritzler J, Lederman MM. Mudido PM, et al. Among authors: lederman mm. Transfusion. 1996 Oct;36(10):860-5. doi: 10.1046/j.1537-2995.1996.361097017170.x. Transfusion. 1996. PMID: 8863771
The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels.
Dezube BJ, Lederman MM, Chapman B, Georges DL, Dogon AL, Mudido P, Reis-Lishing J, Cheng SL, Silberman SL, Crumpacker CS. Dezube BJ, et al. Among authors: lederman mm. J Infect Dis. 1997 Sep;176(3):807-10. doi: 10.1086/517308. J Infect Dis. 1997. PMID: 9291340 Clinical Trial.
Rationale for immune-based therapies for HIV-1 infection.
Valdez H, Al-Harthi L, Landay A, Lederman MM. Valdez H, et al. Among authors: lederman mm. J Lab Clin Med. 1998 Mar;131(3):197-206. doi: 10.1016/s0022-2143(98)90090-7. J Lab Clin Med. 1998. PMID: 9523842 Review. No abstract available.
In vivo analysis of Fas/FasL interactions in HIV-infected patients.
Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. Badley AD, et al. Among authors: lederman mm. J Clin Invest. 1998 Jul 1;102(1):79-87. doi: 10.1172/JCI2691. J Clin Invest. 1998. PMID: 9649560 Free PMC article.
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H. Lederman MM, et al. J Infect Dis. 1998 Jul;178(1):70-9. doi: 10.1086/515591. J Infect Dis. 1998. PMID: 9652425 Clinical Trial.
449 results